Request for Quality Metrics; Notice of Draft Guidance Availability and Public Meeting; Request for Comments; Correction, 47493 [2015-19487]

Download as PDF Federal Register / Vol. 80, No. 152 / Friday, August 7, 2015 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–1051] Modified Risk Tobacco Product Applications: Applications for 10 Products Submitted by Swedish Match North America Inc.; Reopening of Comment Period; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of July 31, 2015 (80 FR 45661). The document reopened the period for public comment on modified risk tobacco product applications (MRTPAs) submitted by Swedish Match North America Inc. for 10 tobacco products and announced the availability for public comment of amendments to the MRTPAs. The document was published with an incorrect paragraph in the Comments section. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy and Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993–0002, 301–796–9115. SUPPLEMENTARY INFORMATION: In FR Doc. 2015–18782, appearing in the Federal Register of Friday, July 31, 2015, the following correction is made: On page 45661, in the third column, the first paragraph of the Comments section is corrected to read: SUMMARY: tkelley on DSK3SPTVN1PROD with NOTICES A. General Information About Submitting Comments Interested persons may submit either electronic comments regarding this document to https://www.regulations.gov or written comments to the Division of Dockets Management (see ADDRESSES). It is only necessary to send one set of comments. Identify comments with the docket number found in brackets in the heading of this document. B. Public Availability of Comments Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at https:// www.regulations.gov. As a matter of Agency practice, FDA generally does not post comments submitted by individuals in their individual capacity on https://www.regulations.gov. This is determined by information indicating VerDate Sep<11>2014 18:24 Aug 06, 2015 Jkt 235001 that the submission is written by an individual, for example, the comment is identified with the category ‘‘Individual Consumer’’ under the field entitled ‘‘Category (Required),’’ on the ‘‘Your Information’’ page on https:// www.regulations.gov. For this docket, however, FDA will not be following this general practice. Instead, FDA will post on https://www.regulations.gov comments to this docket that have been submitted by individuals in their individual capacity. If you wish to submit any information under a claim of confidentiality, please refer to 21 CFR 10.20. C. Information Identifying the Person Submitting the Comment Please note that your name, contact information, and other information identifying you will be posted on https:// www.regulations.gov if you include that information in the body of your comments. For electronic comments submitted to https:// www.regulations.gov, FDA will post the body of your comment on https:// www.regulations.gov along with your state/province and country (if provided), the name of your representative (if any), and the category identifying you (e.g., individual, consumer, academic, industry). For written submissions submitted to the Division of Dockets Management, FDA will post the body of your comments on https://www.regulations.gov, but you can put your name and/or contact information on a separate cover sheet and not in the body of your comments. Dated: August 3, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–19418 Filed 8–6–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2015–D–2537] Request for Quality Metrics; Notice of Draft Guidance Availability and Public Meeting; Request for Comments; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of July 28, 2015 (80 FR 44973). The document published with an SUMMARY: PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 47493 incorrect docket number. This document corrects that error. Lisa Granger, Office of Policy, Planning, Legislation, and Analysis, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993–0002, 301– 796–9115. SUPPLEMENTARY INFORMATION: In FR Doc. 2015–18448, appearing on page 44973, in the Federal Register of Tuesday, July 28, 2015, the following correction is made: On page 44973, in the first column, in the headings section of the document, ‘‘[Docket No. FDA–2014–D–2537]’’ is corrected to read ‘‘FDA–2015–D–2537’’. FOR FURTHER INFORMATION CONTACT: Dated: August 3, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–19487 Filed 8–6–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Designation of a Class of Employees for Addition to the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: HHS gives notice of a decision to designate a class of employees from the Westinghouse Electric Corporation in Bloomfield, New Jersey, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, NIOSH, 1090 Tusculum Avenue, MS C– 46, Cincinnati, OH 45226–1938, Telephone 1–877–222–7570. Information requests can also be submitted by email to DCAS@CDC.GOV. SUPPLEMENTARY INFORMATION: SUMMARY: Authority: 42 U.S.C. 7384q(b). 42 U.S.C. 7384l(14)(C). On July 31, 2015, as provided for under 42 U.S.C. 7384l(14)(C), the Secretary of HHS designated the following class of employees as an addition to the SEC: All Atomic Weapons Employees who worked at the facility owned by Westinghouse Electric Corp., in Bloomfield, New Jersey, during the period from February E:\FR\FM\07AUN1.SGM 07AUN1

Agencies

[Federal Register Volume 80, Number 152 (Friday, August 7, 2015)]
[Notices]
[Page 47493]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-19487]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-D-2537]


Request for Quality Metrics; Notice of Draft Guidance 
Availability and Public Meeting; Request for Comments; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of July 28, 2015 (80 FR 44973). 
The document published with an incorrect docket number. This document 
corrects that error.

FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy, 
Planning, Legislation, and Analysis, Food and Drug Administration, 
10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993-
0002, 301-796-9115.

SUPPLEMENTARY INFORMATION: In FR Doc. 2015-18448, appearing on page 
44973, in the Federal Register of Tuesday, July 28, 2015, the following 
correction is made:
    On page 44973, in the first column, in the headings section of the 
document, ``[Docket No. FDA-2014-D-2537]'' is corrected to read ``FDA-
2015-D-2537''.

    Dated: August 3, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-19487 Filed 8-6-15; 8:45 am]
BILLING CODE 4164-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.